Saratoga Research & Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Saratoga Research & Investment Management's LLY Position: Q2 2026 in Review
Saratoga Research & Investment Management increased its Eli Lilly (LLY) stake by 16% in Q2 2026, buying an estimated $7.5M and bringing the position to 53,862 shares worth $64.6M. The position accounts for 3.53% of the portfolio, ranked #11.
Saratoga Research & Investment Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Saratoga Research & Investment Management held 53,862 shares of Eli Lilly worth $64.6M as of Q2 2026.
- Saratoga Research & Investment Management bought 7,337 Eli Lilly shares in Q2 2026, an estimated $7.5M.
- Eli Lilly made up 3.53% of Saratoga Research & Investment Management's portfolio in Q2 2026, its #11 holding.
- Saratoga Research & Investment Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
- 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Saratoga Research & Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.